Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl

Journal of Psychiatry and Neuroscience

Volumn 30, Issue 2, 2005, Pages 133-135

  Görker, Işik ^a,b   Tüzün, Ümran ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ARGININE; BENZOIC ACID; CARBOXYLIC ACID; THIORIDAZINE; UREA;

AGGRESSION; AMINO ACID DEFICIENCY; ARGININE DEFICIENCY; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; EDUCATION; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; HUMAN; HYPERACTIVITY; INFANTILE AUTISM; PRESCHOOL CHILD; PROTEIN RESTRICTION; SPEECH THERAPY; SYMPTOMATOLOGY; TREATMENT OUTCOME; UREA CYCLE; AUTISM; INBORN ERROR OF METABOLISM; METABOLISM; PSYCHOLOGICAL ASPECT;

AUTISTIC DISORDER; CHILD, PRESCHOOL; FEMALE; HUMANS; METABOLISM, INBORN ERRORS; UREA;

EID: 17544371896     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Summar ML, Tuchman M. Urea cycle disorders overview. Gene reviews. Seattle (WA): University of Washington; 2003.
2. Menkes JH. Metabolic diseases of the nervous system. In: Menkes JH, editor. Textbook of child neurology. Baltimore: Williams & Wilkins; 1995. p. 29-151.
3. Semin R. Zekanin Degerlendirilmesi. Binet-Stanford Testlerinin Istanbul Çocuklarina Standartlanmasi. Istanbul: Istanbul Üniversitesi Edebiyat Fakültesi Yayinlari; 1972.
4. Nagata N, Matsuda I, Matsura T, Oyanagi K, Tada K, Narisawa K, et al. Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. Am J Med Genet 1991;40:477-81.
5. Roth KS, Steiner RD. Ornithine transcarbamylase deficiency. eMedicine 2002;3:2.
6. Spada M, Guardamagna O, Rabier D, van der Meer SB, Parvy P, Bardet J, et al. Recurrent episodes of bizarre behavior in a boy with ornithine transcarbamylase deficiency: diagnostic failure of protein loading and allopurinol challenge tests. J Pediatr 1994; 125(2):249-51.
7. Batshaw ML, Msall M, Beaudet AL, Trojak J. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr 1986;108(2):236-41.
8. Christopher R, Rajivnath V, Shetty T. Arginase deficiency. Indian J Pediatr 1997;64(2):266-9.
9. Trauner DA. Cognitive and behavioural manifestations of metabolic and chromosomal disorders. In: Frank Y, editor. Pediatric behavioural neurology. New York: CRC Press; 1996. p. 251-68.
10. Graham PJ, Turk J. Psychiatric aspects of pediatric disorders. In: Lewis M, editor. Child and adolescent psychiatry. Baltimore: Williams & Wilkins; 1996. p. 989-1005.
11. Lotspeich LJ, Ciaranello RD. The neurobiology and genetics of infantile autism. Int Rev Neurobiol 1993;35:87-129.
12. Whiteley P, Shattock P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 2002;6(2):175-83.
13. Trifiletti RR, Packard AM. Metabolic disorders presenting with behavioral symptoms in the school-aged child. Child Adolesc Psychiatr Clin N Am 1999;8(4):791-806.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: the Association; 1994.